Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Enbrel
Pharma
Amid buzz for Amgen's obesity drug, company sees revenue boost
The buzz about Amgen’s obesity pipeline overshadowed the company’s solid work on the top line as revenue came in at $7.4 billion for a 22% increase.
Kevin Dunleavy
May 3, 2024 9:05am
In lawsuit, Amgen slams Colorado's proposed Enbrel price cap
Mar 26, 2024 12:30pm
Amgen, J&J to see largest impact from IRA negotiations: Moody's
Sep 7, 2023 9:05am
Amgen launched Humira biosim to its own detriment
Apr 28, 2023 11:05am
Pfizer makes major splash in Ireland, where it plans to hire 500
Dec 1, 2022 8:44am
Pricing pressure weighs on Amgen as Lumakras declines
Nov 4, 2022 11:32am
